SS-31 (Elamipretide) is a synthetic tetrapeptide designed to selectively target cardiolipin on the inner mitochondrial membrane. Extensive biogerontology research suggests that SS-31 optimizes electron transport chain efficiency, reduces mitochondrial ROS generation, and restores cellular ATP production in damaged cells.

"SS-31 binds to cardiolipin to stabilize mitochondrial cristae structures, preventing electron leakage during respiratory stress."

Advanced metabolic papers are searchable via PubMed at PubMed SS-31 Research Index and detailed molecular structures are accessible at the PubChem Elamipretide Portal. Preclinical models focus on cellular ischemic protection.

Key Areas of Investigation:

• Cardiolipin Membrane Targeting: Evaluating electrostatic interactions with mitochondrial lipids in vitro.
• Oxidative Phosphorylation Stabilization: Studies on electron transport chain complex I and IV alignment.
• Ischemia Reperfusion Defense: Assessing cellular survivability during oxygen deprivation assays.

This material is supplied exclusively as a lyophilized solid for laboratory research and analytical evaluation, and is strictly not for human or therapeutic use.